An experiment was conducted to investigate the impact of β-mannanase inclusion on growth performance, viscosity, and energy utilization in broilers fed diets varying in galactomannan (GM) concentrations. Treatments were arranged as a 3 (GM concentration) × 3 (β-mannanase inclusion) factorial randomized complete block design with 12 replicates of 29 male broilers per replicate for a 42-d experiment. Efforts were made to reduce the amount of soybean meal, and thus GM, in the basal diet with guar gum included at 0, 0.21, or 0.42% to achieve a GM supplementation of 1,500 and 3,000 ppm, respectively. Betamannanase was included at 0, 200, or 400 g/ton. Broilers were fed a starter (d 0 to 14), grower (d 15 to 28), and finisher diets (d 29 to 42). Growth performance was monitored and ileal contents collected on d 14, 28, and 42 to determine ileal digestible energy (IDE) and intestinal viscosity. Increasing levels of GM negatively (P < 0.05) influenced body weight (BW) following the starter and grower periods and increased (P < 0.01) mortality corrected feed conversion ratio (FCR) throughout the study. Reduced growth performance was associated with increased (P < 0.05) intestinal viscosity and decreased (P < 0.05) IDE when GM inclusion was increased. Inclusion of β-mannanase in diets containing supplemental GM on d 28, increased average BW to levels similar to diets without supplemental GM. Improvements in FCR were also observed with β-mannanase inclusion in diets containing supplemental GM. Ileal digestible energy was increased (P < 0.05) with the addition of β-mannanase on d 28 of age. Multiple interactions in growth performance, intestinal viscosity, and IDE were associated with β-mannanase administration. In conclusion, β-mannanase improved IDE, reduced intestinal viscosity, and improved growth performance; however, the observed benefit was dependent upon dietary GM concentration.
INTRODUCTION
Cereal grains are common ingredients in US commercial broiler diets, and these grains contain non-starch polysaccharides (NSPs). Dietary NSPs are indigestible by poultry but represent a potential energy source that can be utilized with the addition of enzymes (Meng et al., 2005) . Soybean meal (SBM) is a primary source of vegetable protein and contains 3% soluble NSP and 16% insoluble NSP (Irish & Balnave, 1993) , consisting mainly of mannans and galactomannans (GMs) (Slominski, 2011) . Beta-mannan, or galactomannan, is a polysaccharide and has repeating units of mannose containing galactose and/or glucose (Carpita & McCann, 2000; Hsiao et al., 2006) . Galactomannan content in dehulled SBM has been reported at levels from 1.02 to 1.51% (Hsiao et al., 2006) . Although galactomannan content of SBM is in low concentrations, it is a concern for nutritionists because it has anti-nutritive properties. Mannans are surface components of multiple pathogens, and the innate immune system reacts to antigens on these pathogens. Mannans in the diet can stimulate the innate immune system and lead to a purposeless energy draining immune response (Hsiao et al., 2006) . Inclusion of exogenous enzymes could be a viable option to mitigate some of these negative effects in diets containing soybean meal.
Specifically, β-mannanase targets galactomannan present in the diet, of which the main source is soybean meal. The inclusion of β-mannanase in broiler diets has shown to increase nitrogen-corrected apparent metabolizable energy (AMEn), body weight gain, and improve feed conversion ratio (Daskiran et al., 2004; Jackson et al., 2004; Lee et al., 2005; Zangiabadi & Torki, 2010) . Basal diets in this study were formulated with minimal SBM inclusion, and dietary guar gum was included at varying levels to increase levels of galactomannan across treatments. Galactomannan in guar gum has a similar galactose: mannose ratio to SBM with a 0.1% difference (Whistler and Smart, 1953; Whistler and Saarnio, 1957; Hsiao et al., 2006) . β-mannanase inclusion has been reported to have immunological benefits. When 549 including β-mannanase into broiler diets, reductions in lesion development were observed in broilers subjected to a necrotic enteritis model through a combined Eimeria species and Clostridium perfringens challenge (Jackson et al., 2003) . Additional benefits have been attributed to the reduction of viscous material in diets with elevated galactomannan contents (Lee et al., 2003a) . Beta-mannanase inclusion has also shown to increase average body weight and reduce FCR in broilers fed a reduced energy diet (Williams et al., 2014) .
Benefits from β-mannanase inclusion in broiler diets has been well documented (Jackson et al., 2003; Lee et al., 2003a; Jackson et al., 2004; Lee et al., 2005) , as well as the need for increasing the level of substrate available for β-mannanase. However, the level of β-mannanase in combination with galactomannan concentrations required to achieve maximum broiler performance is not known. Further, minimal research is available on the effects of β-mannanase in combination with galactomannan concentrations on the modern broiler. Therefore, the objective of the current experiment was to investigate the impact of β-mannanase inclusion on growth performance, intestinal viscosity, and ileal digestible energy in the modern broiler fed diets varying in galactomannan concentrations.
MATERIALS AND METHODS

Experimental Design
The effect of β-mannanase (Hemicell R -HT, Elanco Animal Health, Greenfield, IN) inclusion on broiler growth performance and energy utilization when administered in the presence of various dietary GM concentrations was evaluated in a completely randomized block design during a 42 d grow-out. The experimental design consisted of a 3 (β-mannanase: 0, 200, or 400 g/ton) × 3 (GM: 0, 1,500, or 3,000 ppm) factorial to create a total of 9 treatments in complete block design.
Experimental Diets
Diets were corn and SBM based and formulated in an effort to reduce SBM to ultimately decrease the amount of GM content in the control diet (Table 1) . Therefore, corn gluten meal, distillers' dried grains with solubles (DDGS), and meat and bone meal (MBM) were included in the diet as alternative protein sources. For each feeding phase, a large control diet was manufactured and split into 9 equal treatments. Treatments consisted of β-mannanase 1 at 0, 200, or 400 g/ton and GM 2 at 0, 1,500, or 3000 ppm. Guar gum inclusion rate was determined using this concentration to achieve the desired GM content of 1,500 and 3,000 ppm. One unit of β-mannanase activity is defined as the amount of enzyme which generates 0.72 microgram of reducing sugars per minute from a mannose-containing substrate at pH 6.6 and temperature of 40 • C. Sand was used as a filler to ensure all inclusions were equal. Pelleting temperatures were maintained between 74
• and 76 • C. Lower pelleting temperatures were targeted to ensure maximum level of enzyme recovery was achieved. All diets were pelleted with the exception of the starter diet, which was pelleted and then crumbled. The starter diet was fed from d 0-14, grower from d 15-28, and finisher from d 29-42. Titanium dioxide was included in all dietary phases as an indigestible marker to determine ileal digestible energy (IDE). Nutrient analysis and enzyme activity in the finished feed was analyzed and verified by the manufacturer (Table 1) . Galactomannan concentration of the soybean meal and guar gum used in the experiment was estimated from the total mannose according to the method of Englyst and Cummings (1984) . This analysis resulted in a calculated analyzed concentration of 1.1% for the soybean meal and 74% in the guar gum used for the experiment. The guar gum used in this experiment carried a guaranteed concentration of 70% GM in the gum. As the calculated analyzed value and guaranteed analysis was similar, the value of 70% was used for the calculation of guar gum inclusion to meet the GM target levels. Guar gum GM was chosen for use in this study as its galactose to mannose ratio is similar to GM ratio found in soybean meal. Crude protein was determined by combustion (AOAC method 990.03); calcium, total phosphorus, and sodium determined by wet ash Inductively Coupled Plasma (AOAC 985.01 M). Acid detergent fiber was determined using an Ankom digestion unit (AOAC method 973.18); and an ether extraction method was used to determine crude fat (AOAC method 920.39).
Animals and Management Practice
On day of hatch, 3,132 male broiler chicks were randomly allotted to floor pens and dietary treatments based on initial body weight. The study consisted of 108 total pens with 12 blocks of 9 pens, each containing 29 chicks at one d of age. The pens were 1.672 m 2 floor pens with nipple drinkers and a tube feeder. Feed and water were available ad libitum. Chicks were provided age appropriate supplemental heat and were subjected to an industry type lighting program. The lighting program at the Texas A&M research center was: d 1-8, 24 h of light at 20 lux foot-candles, d 9-18, 16 h of light at 8 lux foot-candle, d 19-32, 18 h of light at 2 lux foot-candle and, d 33 to termination, 20 h of light at 1 lux foot-candle. Broilers were reared on used litter (3 previous flocks) and top-dressed with fresh pine shavings. All broilers and feed were weighed by pen on d 14, 28, and 42 to determine average body weight (BW), mortality adjusted feed conversion ratio (FCR), feed consumption (FC), and cumulative FCR (cFCR). Ileal digestible energy (IDE) and intestinal viscosity 1 Hemicell R , HT-Elanco Animal Health, Greenfield, IN, Expected β-mannanase activity 35 MMU at 200 g/ton and 70 MMU at 400 g/ton with β-mannanase recovery for the starter at 36.6 MMU at 200 g/ton and 54.5 MMU at 400 g/ton; β-mannanase recovery for the grower at 25.8 MMU at 200 g/ton and 53.7 MMU at 400 g/ton; β-mannanase recovery for the finisher at 41.9 MMU at 200 g/ton and 63.5 MMU at 400 g/ton. One unit of β-mannanase activity is defined as the amount of enzyme which generates 0.72 microgram of reducing sugars per minute from a mannose-containing substrate at pH 6.6 and temperature of 40
• C. 2 PROCOL R -POLYPRO-Minneapolis, MN. 3 Animal Vegetable Blend. 4 Calcium content of 38.0%. 5 Phosphorus content of 21% and calcium content of 16%. 6 Trace mineral premix added at this rate yields per kg of diet 149.6 mg manganese, 125.1 mg zinc, 16.5 mg iron, 1.7 mg copper, 1.05 mg iodine, 0.25 mg selenium, a minimum of 6.27 mg calcium, and a maximum of 8.69 mg calcium. The carrier is calcium carbonate and the premix contains less than 1% mineral oil.
7 Vitamin premix added at this rate yields per kg diet 11,023 IU vitamin A, 3,858 IU vitamin D 3 , 46 IU vitamin E, 0.0165 mg B 12 , 5.845 mg riboflavin, 45.93 mg niacin, 20.21 mg d-pantothenic acid, 477.67 mg choline, 1.47 mg menadione, 1.75 mg folic acid, 7.17 mg pyroxidine, 2.94 mg thiamine, 0.55 mg biotin. The carrier is ground rice hulls.
8 Biocox R , Active drug ingredient salinomycin sodium, 60 g/lb of activity Huvepharma Inc., Peachtree City, GA (60 g/ton inclusion).). As an aid in the prevention of coccidiosis caused by Eimeria necatrix, Eimeria tenella, Eimeria acervulina, Eimeria brunette, Eimeria mivati, and Eimeria maxima.
9 Optiphos R , Huvepharma Inc., Peachtree City, GA. 10 Digestible amino acid concentrations were calculated using the prediction equations in the NRC (1994). measured in centipoise (cP) were determined on d 14 (5 birds per replicate pen), d 28 (4 birds per replicate pen), and d 42 (3 birds per replicate pen). Ileal samples were pooled, homogenized and divided into 2 aliquots with one used for the determination of IDE and one used to determine intestinal viscosity. For IDE determination, samples were dried at 100
• C for 24 h and gross energy of feed and ileal digesta were determined using a Parr 6400 bomb calorimeter (Parr Instrument Company, Moline, IL). Titanium concentration was determined via protocol outlined by Short et al. (2006) . For this procedure, a half gram of each dried sample was weighed and ashed. Following ashing, each sample was titrated with 10 mL of sulfuric acid (7.4 M) and then boiled at 200
• C for 2 h until dissolved. Samples were then titrated with 20 mL of 30% hydrogen peroxide, and brought to 100 mL using distilled water. Samples were then analyzed for absorption using a Thermo Fisher Scientific Genesys 10S UV-Vis Spectrophotometer (Thermo Fisher Scientific, Waltham, MA) at 410 nm. IDE was calculated using the following equation (Scott et al., 1982) :
where Gross Ef is gross energy present in the feed, GE is gross energy in the ileal contents, Tif/Tii is the ratio of titanium presence in the feed and ileal contents.
To determine intestinal viscosity, samples were centrifuged at 3,500 × g for 10 min (Lee et al., 2003b) .
Viscosity was determined by adding 0.5 mL of supernatant into a Brookfield DV2T Cone and Plate Viscometer (Brookfield Engineering Laboratories, Middleboro, MA) with a cP-40 spindle at 12 rpm at 40
• C to represent the internal temperature of a chicken. Viscosity readings were recorded after 30 s. All animal husbandry procedures were conducted in accordance with an approved animal use protocol (IACUC).
Statistical Analysis
All data were subject to a 3 × 3 factorial analysis of variance (ANOVA) using the GLM model (SPSS software) including diet and enzyme as fixed factors and block as a random factor. Main effect means were deemed significantly different at P ≤ 0.05. In the case of an interaction, data were subject to a one-way ANOVA with means deemed significantly different at P ≤ 0.05 and means deemed significantly different were further separated by Duncan's Multiple Range Test. For each parameter, pen was used as the experimental unit. Equal variances were confirmed using Levine's test of equal variances prior to analysis.
RESULTS
Body Weight (BW)
Galactomannan levels decreased BW on d 14 in broilers fed high level of GM diets when compared to control and low GM diets (Table 2 ). An interaction (P = 0.024) was present between β-mannanase and GM on d 28 regarding average BW. In broilers fed diets without β-mannanase, increasing levels of GM resulted in a decrease (P < 0.05) in average male BW. Inclusion of β-mannanase at 200 and 400 g/ton in diets containing high supplemental GM increased (P < 0.05) d 28 BW compared to high GM diets without β-mannanase. At the conclusion of the trial on d 42, the inclusion of β-mannanase or supplemental GM did not impact average BW.
Feed Consumption
No differences were observed in average feed consumption (FC) for the starter and finisher phases with the inclusion of β-mannanase or supplemental GM (Table 2) . During the grower phase, broilers fed diets containing the highest level of GM yielded an increase (P = 0.045) in FC when compared to no supplemental GM, with the low level of GM had intermediate results.
Cumulative Mortality-Adjusted Feed Conversion Ratio
Inclusion of β-mannanase or supplemental GM did not impact mortality-adjusted FCR (cFCR) during the starter and finisher phases (Table 2) . During the grower phase, an interaction (P < 0.001) was present between β-mannanase and GM content. Broilers fed diets without β-mannanase had an increase (P < 0.05) in FCR with increasing levels of GM. Dietary GM addition increased (P < 0.001) the FCR during the grower phase (Table 2 ). In broilers fed diets containing low and high level of GM, β-mannanase inclusion improved the FCR during the grower phase (P < 0.001).
An interaction between β-mannanase and GM was observed through d 0 to 28, d 14 to 42, and d 0 to 42 with respect to cFCR (Table 3) . Cumulatively, through d 0 to 28 and d 0 to 42, broilers fed diets without β-mannanase had higher cFCRs (P < 0.05) as concentrations of GM increased. At the initiation of the trial through d 28, broilers fed diets with β-mannanase, regardless of concentration, had increased cFCR at the high level of GM inclusion when compared to diets containing the low level of GM inclusion and the control. In diets containing supplemental GM, inclusion of β-mannanase at 200 and 400 g/ton reduced (P < 0.05) cFCR from d 0 to 28 compared to diets without β-mannanase. Galactomannan supplementation did not impact cFCR through d 0 to 42 when included in diets containing β-mannanase at 200 g\ton. However, broilers fed diets with the inclusion of β-mannanase at 400 g/ton and the high concentration of GM, had increased cFCR when compared to no GM supplementation on d 14 to 42. At the conclusion of the trial (d 0 to 42), increased cFCR was observed in diets containing β-mannanase at 400 g/ton and high levels of GM supplementation compared to the low concentration of GM and the control (P < 0.05). Inclusion of β-mannanase at 200 and 400 g/ton in diets containing high levels of GM reduced (P < 0.05) cFCR through d 42 compared to diets without β-mannanase.
Ileal Digestible Energy
On d 14, an interaction (P = 0.002) was observed between β-mannanase and GM concentrations with respect to IDE (Table 3) . Inclusion of β-mannanase at 400 g/ton in diets without supplemental GM yielded an increase (P < 0.05) in d 14 IDE compared to diets without β-mannanase. The inclusion of β-mannanase at 200 g/ton in diets supplemented with high levels of GM increased (P < 0.05) IDE on d 14 compared to diets without β-mannanase and β-mannanase at 400 g/ton. In diets containing β-mannanase at 400 g/ton, supplementation of high GM reduced (P < 0.05) d 14 IDE compared to diets without supplemental GM. On d 28, increasing levels of GM did not impact IDE. However, as β-mannanase inclusion increased, there was an increase (P < 0.001) in IDE. Inclusion of β-mannanase or supplemental GM did not impact IDE at the conclusion of the trial on d 42.
Intestinal Viscosity (cP)
An interaction (P < 0.001) was observed between β-mannanase and GM concentrations on d 14 and d 28 with regards to intestinal viscosity (Table 3) . On d 14 and d 28, broilers fed diets without β-mannanase had increased viscosity with increasing concentrations of GM. On d 14, diets containing β-mannanase at 200 g/ton reduced (P < 0.05) viscosity regardless of GM concentration compared to diets without β-mannanase. Beta-mannanase inclusion at 400 g/ton in high GM diets reduced (P < 0.05) viscosity compared to diets without β-mannanase. On d 28, increasing the level of GM in the diet increased (P < 0.05) intestinal viscosity, however, the inclusion of β-mannanase at both inclusion levels reduced (P < 0.05) intestinal viscosity in the high GM diet. On d 42, supplementing diets with high levels of GM increased (P < 0.001) intestinal viscosity compared to diets without supplemental GM and low supplemental GM concentration.
DISCUSSION
Supplementation of exogenous enzymes in broiler diets to improve performance parameters is a common practice within the industry. Galactomannan is commonly found in a variety of poultry feedstuffs, including soybean meal, palm kernel meal, copra meal, and sesame meal (Dierick, 1989) . Diets containing excess GM have shown to negatively impact animal performance, compromising weight gain and feed conversion (Anderson and Warnick, 1964) , as well as glucose and water absorption (Rainbird et al., 1984) . It has been well documented (Lee et al., 2003a; Daskiran et al., 2004; Jackson et al., 2004 ) that corn/soy based diets with the inclusion of β-mannanase have resulted in improvements in performance, nutrient utilization, and enzymatic degradation of GM. Results from the current study demonstrate negative impacts of increasing GM concentrations on overall broiler efficiency, as negative performance effects are exacerbated when GM content was increased. The inclusion of β-mannanase enhanced performance of broilers fed diets containing GM when compared to broilers fed diets containing GM without β-mannanase. Similar results have been observed with performance parameters negatively impacted by increased GM content (Lee et al., 2005) and performance improvements with the inclusion of β-mannanase (McNaughton et al., 1998; Jackson et al., 2004 , Tahir et al., 2005 Zou et al., 2006) .
A reduction (P < 0.05) in average male BW was observed through d 14 and 28 with inclusion of GM at 3,000 ppm in the diet as compared to the diet with no GM inclusion and GM included at 1,500 ppm. Lee et al., (2005) observed similar results with increased levels of GM and subsequent negative impact on broiler BW. Galactomannan inclusion primarily affected young birds which coincide with results observed by others (Nagpal et al., 1971; Thakur & Pradhan, 1975; Verma & McNab, 1982; Patel & McGinnis, 1985) . Growth inhibition with GM inclusion ceased after the grower phase with similar BW during the finisher phase. Equalized broiler BW during the finisher phase suggests that broilers adapted to dietary GM presence over time. Inclusion of β-mannanase to diets containing GM improved BW to levels similar to control during the grower phase. Conflicting results were reported by Lee et al. (2005) with the inclusion of β-mannanase resulting in no differences in BW, regardless of the amount of GM in the diet. Other researchers have emphasized improvements in BW with the inclusion of β-mannanase (McNaughton et al., 1998; Jackson et al., 2004; Tahir et al., 2005; Zou et al., 2006) .
During the grower phase, GM inclusion without β-mannanase addition increased FCR approximately 5.6% and 11.1% in birds fed low GM and high GM diets compared to the control, respectively. Negative impacts on FCR and broiler efficiency have been previously reported with the inclusion of guar products (Thakur & Pradhan, 1975; Patel & McGinnis, 1985; Lee et al., 2005) . Patel & McGinnis (1985) and Lee et al. (2005) reported improvements in FCR with the inclusion of β-mannanase in the presence of increasing levels of GM similar to the response observed in the current study, however, dose did not influence performance as both inclusion rates resulted in similar responses. During this same period (grower), elevating the level of GM increased feed consumption perhaps attributed to a decrease in nutrient digestibility. Increased GM levels in the diet led to an increased intestinal viscosity, which reduces nutrient utilization. However, Lee et al. (2005) reported alternative findings with broilers fed diets containing the highest concentration of galactomannan consuming less feed which correlated with a large decrease in BW.
It has been well documented that increased GM content in diets results in an increase in intestinal viscosity, therefore impeding broiler performance (Lee et al., 2003a,b; Almirall et al., 1995; Choct et al., 1995) . Damaging effects associated with increased viscous digesta are more prominent in younger birds as compared to older birds (Almirall et al., 1995) , suggesting that broilers adapt to dietary challenges. In the current study on d 14 and 28, there was an interaction (P < 0.001) between enzyme and GM inclusion. Intestinal viscosity increased (P < 0.05) as GM content increased in the diet. On d 14, intestinal viscosity decreased (P = 0.005) with β-mannanase addition to diets containing GM. β-mannanase at 200 and 400 g/ton in diets containing 3,000 ppm GM decreased (P < 0.001) intestinal viscosity on d 28, but the enzyme had no impact on the viscosity in birds fed the control and 1,500 ppm GM on d 28.
When including β-mannanase in the diets, regardless of enzyme concentration, the diet containing GM at 1,500 ppm resulted in no differences in intestinal viscosity on d 28 when compared to the diet containing GM at the same concentration without β-mannanase. However, β-mannanase inclusion in diets containing GM at 3,000 ppm resulted in a reduction (P < 0.05) in intestinal viscosity compared to the diet containing GM at the same concentration without β-mannanase. This observation was similar to results reported by Lee et al., (2003a) with β-mannanase inclusion reducing intestinal viscosity with the inclusion of various GM containing ingredients. During the final phase from d 29 to 42, intestinal viscosity was increased in the diets containing the high concentration of GM with the diet containing the low concentration and no added GM being statistically similar, while no effect of β-mannanase was observed.
When evaluating IDE, an interaction (P < 0.002) was present on d 14 between enzyme and GM inclusion. Overall, inclusion of β-mannanase improved IDE in diets with and without additional GM inclusion. Beta-mannanase inclusion at 200 g/ton in the diet containing the high concentration of GM increased IDE by 294 kcal/kg when compared to the diet containing GM at the same concentration without β-mannanase. However, increases in IDE were not dependent on GM inclusion as inclusion of 400 g/ton of enzyme increase IDE in the control diet compared to no enzyme inclusion. During the grower phase, IDE improvements were dependent on β-mannanase inclusion. As β-mannanase inclusion increased in the diet, IDE increased regardless of GM concentration. These results were supported by the improvement in BW during the same phase. Daskiran et al., (2004) reported similar results with GM inclusion reducing nutrient digestibility while inclusion of β-mannanase mitigated the negative impact produced by increased GM concentrations.
Inconsistent responses on viscosity and IDE leave room for speculation that there is an additional reason for improvements in growth performance. As previously mentioned, immunological benefits from the inclusion of β-mannanase have been reported (Jackson et al., 2003; Jackson et al., 2004; Hsiao et al., 2006; Zou et al., 2006) . Mannan presence elicits an innate immune response when an immune response is not required. Jackson et al. (2004) demonstrated that mannans stimulate the innate immune response, leading to unnecessary energy expenditure (Hsiao et al., 2006) which is considered to be a feed induced immune response. Jackson et al. (2004) also observed that reducing the amount of intestinal mannan content resulted in reduced feed induced immune response, ultimately leading to more efficient nutrient utilization and energy expenditure.
The inclusion levels of GM in the current trial of 1,500 and 3,000 ppm negatively impacted overall broiler performance, decreased IDE, and increased intestinal viscosity. Including β-mannanase in the diets did help alleviate some of the negative effects of the increased GM concentration. These data suggest that the ideal increase in substrate level to maximize the efficiency of β-mannanase is between 0 and 1,500 ppm. In the majority of the parameters evaluated, when including β-mannanase in diets containing GM at 1,500 ppm, similar results were observed when compared to diets without GM inclusion.
Galactomannan inclusion negatively affected the growth performance of birds through an intestinal viscosity increase and IDE decrease during the starter and grower phases but birds recovered from this depression during the finisher phase, regardless of enzyme supplementation. β-mannanase addition mitigated some of the negative effects related to GM inclusion during the starter and grower phases, resulting in cumulative reductions in FCR. β-mannanase inclusion can provide beneficial impacts through improvements in growth performance and nutrient utilization however, maximizing this response is dependent upon sufficient dietary GM presence.
